Right atrial pressure represents cumulative cardiac burden in heart failure with preserved ejection fraction.
Heart failure
Prognosis
Pulmonary hypertension
Right atrial pressure
Right heart
Journal
ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
revised:
08
01
2022
received:
18
10
2021
accepted:
06
02
2022
pubmed:
16
2
2022
medline:
26
3
2022
entrez:
15
2
2022
Statut:
ppublish
Résumé
Right-sided filling pressure is elevated in some patients with heart failure (HF) and preserved ejection fraction (HFpEF). We hypothesized that right atrial pressure (RAP) would represent the cumulative burden of abnormalities in the left heart, pulmonary vasculature, and the right heart. Echocardiography was performed in 399 patients with HFpEF. RAP was estimated from inferior vena cava morphology and its respiratory change [estimated right atrial pressure (eRAP)], and patients were divided according to eRAP (3 or ≥8 mmHg). Patients with higher eRAP displayed more severe abnormalities in LV diastolic function as well as right heart structure and function than those with normal eRAP. Cardiac deaths or HF hospitalization occurred in 84 patients over a median follow-up of 19.0 months (interquartile range 6.7-36.9). The presence of higher eRAP was independently associated with an increased risk of the composite outcome (adjusted hazard ratio 2.20 vs. normal eRAP group, 95% confidence interval 1.34-3.62, P = 0.002). Kaplan-Meier curves separating the patients into four groups based on eRAP and E/e' ratio showed that event-free survival varied among the groups, providing an incremental prognostic value of eRAP over E/e' ratio. The classification and regression tree analysis demonstrated that eRAP was the strongest predictor of the outcome followed by right ventricular dimension, E/e' ratio, and estimated right ventricular systolic pressure, stratifying the patients into four risk groups (incident rate 8.8-72.2%). These data may provide new insights into the prognostic role of RAP in the complex pathophysiology of HFpEF and suggest the utility of eRAP for the risk stratification in patients with HFpEF.
Identifiants
pubmed: 35166056
doi: 10.1002/ehf2.13853
pmc: PMC8934927
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1454-1462Informations de copyright
© 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Références
ESC Heart Fail. 2022 Apr;9(2):1454-1462
pubmed: 35166056
ESC Heart Fail. 2020 Nov 2;:
pubmed: 33140584
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
J Card Fail. 2021 May;27(5):577-584
pubmed: 33385523
Eur J Heart Fail. 2018 Sep;20(9):1303-1311
pubmed: 29877602
Circ Heart Fail. 2012 Nov;5(6):720-6
pubmed: 22936826
Int J Cardiovasc Imaging. 2021 Jan;37(1):255-266
pubmed: 32737707
Circ Cardiovasc Imaging. 2020 Nov;13(11):e011430
pubmed: 33198494
JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 1):1460-1470
pubmed: 30343071
J Am Soc Echocardiogr. 2017 May;30(5):444-453.e2
pubmed: 28246005
JACC Cardiovasc Imaging. 2017 Oct;10(10 Pt B):1211-1221
pubmed: 28412423
JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 2):245-257
pubmed: 31202759
JACC Heart Fail. 2018 Aug;6(8):665-675
pubmed: 29803552
Circulation. 2019 Jul 30;140(5):353-365
pubmed: 31132875
Int J Cardiol. 2018 Apr 15;257:143-149
pubmed: 29506686
Eur Heart J. 2018 Aug 7;39(30):2825-2835
pubmed: 29947750
J Am Coll Cardiol. 2020 Sep 1;76(9):1051-1064
pubmed: 32854840
Am J Cardiol. 2017 Jul 15;120(2):274-278
pubmed: 28528661
Nat Rev Cardiol. 2020 Sep;17(9):559-573
pubmed: 32231333
Sci Rep. 2019 Dec 6;9(1):18541
pubmed: 31811258
J Am Coll Cardiol. 2009 Mar 31;53(13):1119-26
pubmed: 19324256
Circ Heart Fail. 2014 Nov;7(6):935-44
pubmed: 25286913
JACC Heart Fail. 2017 Nov;5(11):802-804
pubmed: 29032134
Eur Heart J Cardiovasc Imaging. 2020 Oct 1;21(10):1068-1078
pubmed: 32756989
Circ J. 2019 May 24;83(6):1261-1268
pubmed: 30944274
Eur Heart J. 2018 Aug 7;39(30):2810-2821
pubmed: 29788047
ESC Heart Fail. 2021 Apr;8(2):1494-1501
pubmed: 33539661
Circ Heart Fail. 2017 May;10(5):
pubmed: 28476756
Eur Heart J. 2019 Feb 21;40(8):689-697
pubmed: 30544228
Eur Heart J. 2017 Oct 7;38(38):2874-2878
pubmed: 28431020
JACC Heart Fail. 2017 Nov;5(11):795-801
pubmed: 29032138
Circulation. 2017 Jul 4;136(1):6-19
pubmed: 28381470
Eur Heart J. 2019 Dec 1;40(45):3721-3730
pubmed: 31609443
Eur Heart J Cardiovasc Imaging. 2020 Nov 07;:
pubmed: 33159785
JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 1):1471-1473
pubmed: 30343068
Heart Fail Clin. 2019 Apr;15(2):241-256
pubmed: 30832815
Eur J Heart Fail. 2021 May;23(5):785-796
pubmed: 33565197
J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239
pubmed: 23747642
Circulation. 2014 Dec 23;130(25):2310-20
pubmed: 25391518
Am J Cardiol. 2016 Nov 1;118(9):1356-1362
pubmed: 27600459
Eur Heart J. 2014 Dec 21;35(48):3452-62
pubmed: 24875795
Circ J. 2018 Jun 25;82(7):1959-1962
pubmed: 29695659